S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SRPT Sarepta Therapeutics Inc New

114.50

4.00 (3.62%)

Nov 22 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Sarepta Therapeutics Charts.

Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Sarepta Therapeutics Charts.

Sarepta Therapeutics Inc New News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (3 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments
Wednesday 6 November 2024 (2 weeks ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 31 October 2024 (3 weeks ago) • Business Wire

Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results
Wednesday 23 October 2024 (1 month ago) • Business Wire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 30 September 2024 (2 months ago) • Business Wire

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress
Thursday 26 September 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Monday 16 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 16 September 2024 (2 months ago) • Edgar (US Regulatory)

More Sarepta Therapeutics Inc New News Articles

Global Developments (PK)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

Rennova Health (CE)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions